Pharmacelera, a CataloniaBio & HealthTech member, has been awarded a €1-million grant from the Horizon EIC Accelerator programme (formerly the SME Instrument) for emerging companies to accelerate innovations. The technology start-up received guidance from the Inveniam Group.

Pharmacelera is currently developing and providing software to accelerate drug research and development. One of the most popular is PharmScreen®, which allows users to virtually screen candidate molecules with a huge chemical diversity in proprietary, public or commercial compound libraries. 

You may also be interested in:

Pharmacelera and the Cambridge Crystallographic Data Centre work together on drug discovery

We recommend this video of CataloniaBioHT interviewing them: